Somatic Mutation Profile as a Predictor of Treatment Response and Survival in Unresectable Pancreatic Ductal Adenocarcinoma Treated with FOLFIRINOX and Gemcitabine Nab-Paclitaxel
Article in Cancers (August 2024)
The most recent citing publications are shown below. View all 31 publications that cite this research output on Dimensions.
Article in Cancers (August 2024)
Article in Frontiers in Immunology (February 2024)
Article in Cancer Letters (January 2024)